RNA Competitors & Alternatives
Compare Atrium Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
RNA
Main Stock$8.16
Tradestie Score
62
Market Cap
$6.27B
Revenue Growth
-0.2%
Analyst Upside
+206.4%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.83
|
$202.58M | - | 61 | Compare |
|
EVMN
EVMN
|
$5.21
|
$195.25M | - | 50 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$7.45
|
$170.45M | - | 55 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.50
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.89
|
$154.27M | - | 60 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.54
|
$133.50M | - | 67 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.60
|
$114.01M | - | 67 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$22.20
|
$110.20M | - | 71 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.02
|
$84.52M | - | 39 | Compare |
More RNA Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry